Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
MAIA Biotechnology, Inc. MAIA: This immuno-oncology company has seen the Zacks Consensus Estimate for its current year earnings increasing 44.4% over the last 60 days.

MAIA Biotechnology, Inc. price-consensus-chart | MAIA Biotechnology, Inc. Quote
Byrna Technologies Inc. BYRN: This non-lethal defense technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 25% over the last 60 days.

Byrna Technologies Inc. price-consensus-chart | Byrna Technologies Inc. Quote
OncoCyte Corporation OCX: This precision diagnostics company has seen the Zacks Consensus Estimate for its current year earnings increasing 39.3% over the last 60 days.

OncoCyte Corporation price-consensus-chart | OncoCyte Corporation Quote
Banco Bilbao Vizcaya Argentaria, S.A. BBVA: This banking company has seen the Zacks Consensus Estimate for its current year earnings increasing 4% over the last 60 days.

Banco Bilbao Viscaya Argentaria S.A. price-consensus-chart | Banco Bilbao Viscaya Argentaria S.A. Quote
Harmony Gold Mining Company Limited HMY: This gold-mining company has seen the Zacks Consensus Estimate for its next year earnings increasing 32.9% over the last 60 days.

Harmony Gold Mining Company Limited price-consensus-chart | Harmony Gold Mining Company Limited Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| 4 hours | |
| Oct-07 | |
| Oct-07 | |
| Oct-05 | |
| Sep-30 | |
| Sep-29 | |
| Sep-24 | |
| Sep-24 | |
| Sep-23 | |
| Sep-22 | |
| Sep-17 | |
| Sep-16 | |
| Sep-16 | |
| Sep-15 | |
| Sep-10 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite